Variant report
Variant | nsv878750 |
---|---|
Chromosome Location | chr4:21492445-21520250 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:21510988..21512730-chr4:21514428..21516962,2 | K562 | blood: | |
2 | chr4:21513660..21514733-chr4:21769803..21771071,4 | MCF-7 | breast: | |
3 | chr4:21513432..21514751-chr4:21767040..21768803,10 | MCF-7 | breast: | |
4 | chr4:21513582..21515656-chr4:21764630..21766290,2 | MCF-7 | breast: | |
5 | chr4:21508722..21509309-chr4:21767490..21768052,2 | MCF-7 | breast: | |
6 | chr4:21497861..21500462-chr4:21501332..21503199,2 | K562 | blood: | |
7 | chr4:21513547..21514492-chr4:21769669..21770605,6 | MCF-7 | breast: | |
8 | chr4:21510988..21512730-chr4:21514428..21516962,2 | K562 | blood: | |
9 | chr4:21497861..21500462-chr4:21501332..21503199,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6830109 | chr4:21492445-21492446 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs16871198 | chr4:21492522-21492523 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs373578242 | chr4:21492530-21492531 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs550876087 | chr4:21492535-21492536 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs569245840 | chr4:21492593-21492594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75525090 | chr4:21492601-21492602 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs560846112 | chr4:21492613-21492614 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554192075 | chr4:21492635-21492636 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566335096 | chr4:21492669-21492670 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs552208164 | chr4:21492670-21492671 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs544476941 | chr4:21492671-21492672 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs533899140 | chr4:21492752-21492753 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73107940 | chr4:21492760-21492761 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs576992076 | chr4:21492824-21492825 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544389138 | chr4:21492833-21492834 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187837806 | chr4:21492845-21492846 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545667580 | chr4:21492852-21492853 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542134021 | chr4:21492881-21492882 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs35705890 | chr4:21492894-21492895 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192461678 | chr4:21492904-21492905 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573108372 | chr4:21492908-21492909 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs183187622 | chr4:21492939-21492940 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs565198827 | chr4:21492945-21492946 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs532453641 | chr4:21492977-21492978 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs550791942 | chr4:21492985-21492986 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs562741562 | chr4:21492997-21492998 | Enhancers Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530367355 | chr4:21493036-21493037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548559822 | chr4:21493046-21493047 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs141315169 | chr4:21493066-21493067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs10002399 | chr4:21493084-21493085 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs187064224 | chr4:21493092-21493093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570479805 | chr4:21493143-21493144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs537935256 | chr4:21493164-21493165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556434616 | chr4:21493187-21493188 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574642397 | chr4:21493188-21493189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191837122 | chr4:21493249-21493250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs371574137 | chr4:21493309-21493310 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs553754803 | chr4:21493319-21493320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs573203674 | chr4:21493328-21493329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150239526 | chr4:21493388-21493389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs62301288 | chr4:21493391-21493392 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs138069418 | chr4:21493431-21493432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs10025003 | chr4:21493467-21493468 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs184375746 | chr4:21493468-21493469 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs562752213 | chr4:21493487-21493488 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs530188821 | chr4:21493498-21493499 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs189082793 | chr4:21493561-21493562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs10014758 | chr4:21493575-21493576 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs527972543 | chr4:21493639-21493640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551930171 | chr4:21493662-21493663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17603634 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Cancer | 21637783 | CNVD |
Melanoma | 21693616 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Cervical cancer | 21062161 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Neuroblastoma | 18923191 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Breast cancer | 17133270 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Melanoma | 22183965 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 22737080 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 22183965 | CNVD |
Gastric cancer | 16891809 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:21487600-21492600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
2 | chr4:21492000-21492600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr4:21492200-21492800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
4 | chr4:21492400-21493000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
5 | chr4:21492600-21493000 | Strong transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr4:21493000-21494400 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr4:21494400-21495800 | Strong transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr4:21495800-21496600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
9 | chr4:21496600-21497000 | ZNF genes & repeats | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr4:21497000-21514200 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr4:21500200-21500600 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
12 | chr4:21502400-21503000 | Enhancers | Fetal Heart | heart |
13 | chr4:21513200-21514200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
14 | chr4:21514000-21514200 | Bivalent Enhancer | HUVEC | blood vessel |
15 | chr4:21514200-21514600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr4:21514200-21515800 | Enhancers | Fetal Heart | heart |
17 | chr4:21514600-21516800 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr4:21515800-21519000 | Weak transcription | Fetal Heart | heart |
19 | chr4:21516800-21518600 | Strong transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
20 | chr4:21518600-21521600 | Weak transcription | H9 Derived Neuron Cultured Cells | ES cell derived |
21 | chr4:21519000-21519800 | Enhancers | Fetal Heart | heart |
22 | chr4:21519800-21520200 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |